Influence of carvedilol on hospitalizations in heart failure: Incidence, resource utilization and costs

Journal of the American College of Cardiology

Volumn 37, Issue 6, 2001, Pages 1692-1699

  Al Suwaidi, Jassim ^a   Higano, Stuart T ^a   Holmes Jr , David R ^a   Lennon, Ryan ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE PLANNING; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBAZOLES; CHRONIC DISEASE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEALTH RESOURCES; HEALTH SERVICES RESEARCH; HEART FAILURE, CONGESTIVE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MULTICENTER STUDIES; PROPANOLAMINES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 0035040375     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01190-1     Document Type: Article

References (37)

1. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
2. Changes in mortality from heart failure - United States, 1980-1995
3. National trends in the initial hospitalization for heart failure
4. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995
5. Trends in hospitalization rates for heart failure in the United States, 1973-1986: Evidence for increasing population prevalence
6. Epidemiology of heart failure in the United States
7. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults
8. Spectrum and outcome of congestive heart failure in a hospitalized population
9. The sequelae of hospitalization for congestive heart failure among older adults
10. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries
11. Early readmission of elderly patients with congestive heart failure
12. The effect of digoxin on mortality in patients with heart failure
13. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
14. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure
15. Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the Studies Of Left Ventricular Dysfunction (SOLVD) treatment trial
16. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure
17. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
18. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease
19. A randomized trial of β-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS)
20. The Cardiac Insufficiency Bisoprolol Study (CIBIS II): A randomised trial
21. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metroprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
22. Health Care Investments Analysts Inc Special Study
23. Regression models and life-tables
24. Nonparametric estimation from incomplete observations
25. Statistic aspects of the analysis of data from retrospective studies of disease
26. Effects of beta blockers on symptoms and functional capacity in heart failure
27. β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
28. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure
29. The risk of hospitalization for congestive heart failure among older adults
30. Factors contributing to the hospitalization of patients with congestive heart failure
31. Increased morning incidence of myocardial infarction in the ISAM study: Absence with prior β-adrenergic blockade
32. Effects of recombinant human dNase therapy on healthcare use and costs in patients with cystic fibrosis
33. Health economic consequences of the pharmacological treatment of heart failure
34. Cost effectiveness of carvedilol for heart failure
35. Adverse drug reactions and drug noncompliance as primary causes of admission to a cardiology department